It is a part 3 randomized trial of ivarmacitinib, a JAK inhibitor with selectivity for JAK 1, for adolescents and…
Read More
‘Thrilling’ uveitis pipeline consists of oral, intravitreal and topical therapies
Add matter to electronic mail alerts Obtain an electronic mail when new articles are posted…
Read More
FDA warns of potential dangers with compounded topical finasteride merchandise
April 22, 2025 1 min learn Add matter to e mail alerts Obtain an e mail when new articles are…
Read More
